BiotechTube
Home/Vivazome/Craig Newton
CN

Craig Newton

Non‑Executive Director

Vivazome

Therapeutic Areas

NeurologyNeurodegeneration

Vivazome Pipeline

DrugIndicationPhase
VivaZome TBI TherapyTraumatic Brain Injury (including Post‑Traumatic Epilepsy)Preclinical
VivaZome Stroke TherapyAcute and Chronic StrokePreclinical
VivaZome Tauopathy TherapyNeurodegenerative diseases (tauopathies, dementia)Preclinical

Leadership Team at Vivazome

AF
Anthony Filippis
Non‑Executive Director
XS
Xenia Sango
Chief Executive Officer & Managing Director
DH
David Haylock
Chief Scientific Officer
View full Vivazome profile